EHRA Premium Access

To screen or not to screen for atrial fibrillation (AF)

Event: EHRA 2022
Topic: e-Cardiology/Digital Health
Session type: Symposium
Date: 3 April 2022
Time: 18:05 - 19:05

Session

Become an EHRA member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Consumer-led screening for AF.

Speaker: Doctor C. Albert (Los Angeles, US)
Thumbnail

Clinical outcomes and costs in screening for AF.

Speaker: Doctor E. Svennberg (Stockholm, SE)
Thumbnail

A global perspective on screening.

Speaker: Professor R. Schnabel (Hamburg, DE)
Thumbnail

Future directions: artificial intelligence for early detection of AF.

Speaker: Doctor P. Noseworthy (Rochester, US)
Thumbnail

To screen or not to screen for atrial fibrillation - discussion.

Thumbnail

4 speakers from this session

Doctor Christine Albert

Cedars-Sinai Smidt Heart Institute, Los Angeles (United States of America)
3 presentations
0 follower

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)
11 presentations
4 followers

Professor Renate B Schnabel

University Heart & Vascular Center Hamburg, Hamburg (Germany)
17 presentations
0 follower

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

Related content

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk